Expectedly, HER2.28ζ/PD-L1.BB CAR-T failed to eliminate the tumor completely, but still showed a better anti-tumor effect compared to HER2.28ζ CAR-T cells (Supplementary Fig. S6). This evidence concerns the gene ERBB2 and neoplasm.